Bob Leonard serves as Glytec's Chief Executive Officer and also as President of the company’s Board of Directors. Bob has over 25 years' experience in healthcare in various general management, senior sales and marketing positions. His experience encompasses information technology, hospital information systems, point-of-care devices, disease management and alternate site services; all relevant to the composition of Glytec's unique offering. Previous employers include, PatientKeeper, provider of physician healthcare information systems, which grew from zero to 450 hospital clients during his tenure; McKesson Information Systems, FluidSense (IV /fluid management) and Chartwell, a series of academic medical center partnerships focused on alternate site care. Bob has a proven track record of developing and leading high quality, high performance teams in fast growth companies. In his present role, as in several previous, Bob is responsible for developing and implementing the strategic vision of the company and more importantly, ensuring the company's culture is driven by an unwavering focus on the success and improved health of the hospitals and patients it was created to serve.
John Beneke serves as Glytec's Chief Financial Officer. Prior to joining Glytec in 2012, John was the Chief Financial Officer for M.M. Dillon & Co., a boutique investment bank in Greenwich, CT. Prior to that, John spent 22 years at Morgan Stanley & Co. He was a Managing Director in the Finance Division supporting the Institutional Securities Business. John has held multiple senior operating roles, with experience in Institutional Equity, Capital Markets, Fixed Income Derivatives, and Investment Banking. He has also served a 2 year tour of duty as Head of Investor Relations. John is a Certified Public Accountant, and holds an M.B.A. degree from Rutgers University and a B.A. from Dickinson College.
Robby Booth services as Glytec’s Senior Vice President of Research and Development. Robby has over 17 years of experience in designing and managing secure, mission-critical, technology and services in the rapidly changing information technology and software industry. He joined the company in 2006 and has lead the strategic direction of the company's global research and development activities. Previously Vice President of Product Development at CoMed, he was integral in managing the company's product development design controls and activities to ensure compliance with medical device regulations.
Melanie Mabrey serves as Glytec’s Vice President of Clinical Practice. Melanie is an Acute Care Nurse Practitioner whose clinical practice and scholarship focuses on chronic illness, particularly in endocrinology and diabetes mellitus. Melanie previously served on the faculty of Duke University School of Nursing as an assistant professor, teaching primary care and diabetes in the nurse practitioner program. She has extensive clinical experience in care of the chronically ill patients. Since 2002 her practice has focused extensively on inpatient diabetes management at Duke University Medical Center, Division of Endocrinology. She established and served as the director of their Inpatient Endocrine Nurse Practitioner Program. In 2006, she started a new endocrine/diabetes service at Duke Regional Hospital and went on to serve as the associate medical. Melanie’s doctoral project, publications, and numerous local, regional, national and international presentations focus on care of patients with diabetes across the continuum of care particularly inpatient management. She earned her BSN from East Carolina University in 1993 and her MSN from the University of South Carolina in 2001. She earned the Doctor of Nursing Practice degree from Duke University in 2012, with her doctoral project: Continuous Intravenous Insulin: An Evaluation in Bariatric Patients Outside of the Intensive Care Unit, published in Bariatric Nursing and Surgical Patient Care Journal. Melanie was inducted into Sigma Theta Tau in 1992, is a member of the North Carolina Nurses Association, the American Diabetes Association, the American Association of Diabetes Educators, the American Association of Clinical Endocrinologist, and was honored to be inducted as a Fellow of the American Association of Nurse Practitioners in 2014.
Raymie McFarland serves as Glytec’s Vice President of Quality Initiatives. Raymie joined Glytec after serving as President and Co-Founder of Mantra Healthcare Solutions. He has over 19 years of experience articulating the benefits of quality-oriented administration of innovative chronic disease care tools to leading hospitals and clinicians. Prior to Mantra, Raymie helped develop a Quality Initiatives program at Sanofi-Aventis. At Sanofi he designed numerous tools and protocols to improve quality processes in the care of people with diabetes - including the industry-recognized quality improvement process for inpatient glycemic management and transition of care. While leading glycemic programs for Sanofi, Raymie received numerous national Quality awards for inpatient programming, leadership and medical projects. He has received certifications and training from Society of Hospital Medicine, CMS Readmissions Programming, and Tele-health Remote Monitoring. He also has Quality Lean Processing, Six Sigma, and Quality Institute Certifications. Raymie has lead or been a part of over 35 clinical and financially related diabetes studies which have all been presented or published.
Megan Pietropaolo serves as Glytec’s Chief Legal Counsel. Megan has 13 years of experience representing companies in the health care and technology sector. Prior to joining Glytec, Megan was Senior Legal Counsel at PatientKeeper where she oversaw the legal operations of the company and its merger with HCA. Megan was also an attorney at Gunderson, Dettmer, Stough, Villeneuve, Franklin & Hachigian, LLP where she represented a broad range of companies in the areas of corporate partnering, strategic alliances, intellectual property and technology protection, privacy, advertising, and licensing and commercialization of intellectual property and technology assets. Megan is a graduate of Syracuse University and William & Mary Law School.
Scott Rape serves as Glytec’s Vice President of Client Development. Scott has amassed more than 20 years of experience selling and marketing information technology solutions to the healthcare industry. His experience in this space includes senior sales and management positions with some of the industry's leading software companies such as Multum Information Services, where Scott played an integral part in Cerner Corporation acquiring Multum in 1998. Scott spent 5 years with Cerner before returning to his entrepreneurial roots joining PatientKeeper, Inc., in 2004. Scott systematically grew the Western Region of United States for PatientKeeper by more than 800% during his nine-year tenure. Scott was responsible for many of PatientKeeper's early adopter clients who went on to pave the way for enterprise agreements with some of the nation's largest health systems.
Andrew Rhinehart serves as Glytec’s Chief Medical Officer. Prior to joining Glytec, Andy served as the Diabetologist and Program Director of the Johnston Memorial Diabetes Care Center and the Johnston Memorial Center for Comprehensive Wound Care, since 2008, where he has been in practice since finishing his medical training in 1995. He has been a member of the American Diabetes Association’s (ADA) Professional Practice Committee and the ADA’s Prevention Committee. He also served as the chairman of the ADA’s Primary Care Advisory Group and is presently still an active member. After becoming the first physician to be Board Certified in Advanced Diabetes Management (BC-ADM) by the American Association of Diabetes Educators he has served as a content expert for the BC-ADM Exam and is presently on the BC-ADM Exam Credentialing Oversight Committee. He is also a Certified Diabetes Educator and a Certified Diabetes Technology Clinician. Andy has been awarded recognition from the National Committee for Quality Assurance Diabetes Physician Recognition program for providing high quality care to individuals with diabetes since 2002. He frequently lectures to patients and providers regarding diabetes and its related conditions. Andyhas lectured extensively to providers and patients regarding diabetes, inpatient glycemic control, and diabetes related complications. He also served as the Physician Champion for the Inpatient Glycemic Control Initiative at Johnston Memorial and all of Mountain State Health Alliance, his region's largest healthcare system with 13 hospitals, serving 29 counties in Tennessee, Virginia, Kentucky and North Carolina. Rhinehart is a Pennsylvania native, attended .The University of Maryland School of Medicine and completed his Internal Medicine Residency training at East Tennessee State University, serving as chief resident in his final year of training.
Bob Salitsky serves as Glytec’s Chief Technology Officer. Bob brings more than 25 years of experience with infrastructure software, mobile applications and Internet technology development to Glytec. Prior to joining Glytec, Bob was Vice President of Engineering at Advanced Practice Strategies where he built an innovative, patented e-learning platform that assess clinicians' knowledge and judgment and delivers prioritized, personalized learning content. Prior to joining APS, Bob was CTO of inStream Media where he rapidly built a technology platform to launch inStream's targeted retail POS advertising business that has delivered over 3 billion targeted ads and counting to consumers. Prior to joining inStream, Bob was Vice President of Engineering and CTO of PatientKeeper where he led development teams in designing and developing best-in-class physician information systems, from initial product architecture and development to successful nationwide implementation. Bob also served as Vice President of Engineering at HighPoint Systems and as Senior Technologist for Vicinity Corporation. Bob holds a Bachelor of Science degree in Engineering Sciences and Computer Science from Dartmouth College.